1. Home
  2. OVBC vs IPHA Comparison

OVBC vs IPHA Comparison

Compare OVBC & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ohio Valley Banc Corp.

OVBC

Ohio Valley Banc Corp.

HOLD

Current Price

$43.07

Market Cap

208.5M

Sector

Finance

ML Signal

HOLD

Logo Innate Pharma S.A. ADS

IPHA

Innate Pharma S.A. ADS

SELL

Current Price

$1.87

Market Cap

189.5M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
OVBC
IPHA
Founded
1872
1999
Country
United States
France
Employees
N/A
163
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
208.5M
189.5M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
OVBC
IPHA
Price
$43.07
$1.87
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$5.75
AVG Volume (30 Days)
39.5K
8.8K
Earning Date
04-28-2026
03-26-2026
Dividend Yield
2.22%
N/A
EPS Growth
42.67
N/A
EPS
0.91
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$180.36
Revenue Next Year
N/A
N/A
P/E Ratio
$46.82
N/A
Revenue Growth
N/A
N/A
52 Week Low
$31.61
$1.18
52 Week High
$51.25
$2.63

Technical Indicators

Market Signals
Indicator
OVBC
IPHA
Relative Strength Index (RSI) 36.80 51.21
Support Level $39.07 $1.73
Resistance Level $45.64 $1.80
Average True Range (ATR) 2.17 0.09
MACD -0.63 -0.01
Stochastic Oscillator 13.55 27.60

Price Performance

Historical Comparison
OVBC
IPHA

About OVBC Ohio Valley Banc Corp.

Ohio Valley Banc Corporation is a financial holding company. The bank is a full-service financial institution offering a blend of commercial and consumer banking services in Southeastern Ohio and western West Virginia. The banking services offered by the bank include the acceptance of deposits in checking, savings, time and money market accounts; the making and servicing of personal, commercial, and student loans; and the making of construction and real estate loans. It also offers individual retirement accounts, safe deposit boxes, wire transfers, and other standard banking products and services.

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. The company's approach includes therapeutic modalities such as monoclonal antibodies, multispecific NK cell engagers through its ANKET platform, and antibody-drug conjugates (ADC). Its portfolio includes lacutamab, which is being studied for cutaneous T-cell lymphomas and peripheral T-cell lymphomas, and monalizumab, which is being developed in collaboration with AstraZeneca for non-small cell lung cancer. The company's revenue mainly consists of revenues from collaboration and licensing agreements and government financing for research expenditure in the form of research tax credits, as well as other grants.

Share on Social Networks: